Breast Cancer Research

official impact factor 5.79

Open Access Highly Access Research article

Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells

Rafat A Siddiqui3,1,2*, Mustapha Zerouga1, Min Wu1, Alicia Castillo1, Kevin Harvey1, Gary P Zaloga1,2 and William Stillwell3,1

Author Affiliations

1 Methodist Research Institute, Clarian Health Partners, Indianapolis, IN, USA

2 Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

3 Department of Biology, Indiana University-Purdue University, Indianapolis, IN, USA

For all author emails, please log on.

Breast Cancer Research 2005, 7:R645-R654 doi:10.1186/bcr1036

Published: 7 June 2005

Additional files

Additional File 1:

A Word document containing mass spectrometry data for propofol-DHA and propofol-EPA conjugates are presented as 1.

Format: DOC Size: 2.9MB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data